News & Updates
Filter by Specialty:
Detecting Alzheimer’s disease biomarkers: Timing matters
A 20-year nested case–control study in China has shown sequential and temporal changes in biomarkers 6–18 years before diagnosis of Alzheimer’s disease (AD). Accelerated changes in cerebrospinal fluid (CSF) biomarkers were found after the onset of cognitive impairment, followed by plateaus at AD diagnosis.
Detecting Alzheimer’s disease biomarkers: Timing matters
02 May 2024
Thrombectomy tied to better functional outcomes in large ischaemic stroke patients
Endovascular thrombectomy (EVT) in addition to medical care results in significantly improved functional outcomes at 1 year in acute ischaemic stroke patients with a large core infarct compared with medical care alone, as shown in the SELECT2 study. This benefit persists across ischaemic core strata on imaging.
Thrombectomy tied to better functional outcomes in large ischaemic stroke patients
01 May 2024
Improved cervical screening uptake among local South Asian women following CUHK training
Expansion of a territory-wide cervical screening programme to train a group of local South Asian women has enabled education regarding cervical cancer and screening services among their peers, and considerably improved screening uptake.
Improved cervical screening uptake among local South Asian women following CUHK training
01 May 2024
Long-term lecanemab reduces cognitive decline in early AD
Treatment with lecanemab continue to provide benefits to patients with early Alzheimer’s disease (AD) through 24 months, according to the results of the ongoing open-label extension study of Clarity AD. Those who have been treated much later also show disease improvements.